Post-hoc Analysis of Descartes-08, BCMA-directed mRNA CAR-T Therapy, in Biologic Non-responsive Versus Biologic Naive Generalized Myasthenia Gravis: Results from a Phase 2b Randomized Trial

Descartes-08 - Cartesian Therapeutics

Milos Miljkovic1; Tuan Vu2; Hacer Durmus3; Christopher Jewell1; Hafsa Kamboh1; Eva Rybak1; Renee Fedak1; Tahseen Mozaffar4; James Howard5

Mar 6, 2026